Use of growth hormone for prevention or treatment of effects of aging.
Decreases in growth hormone (GH) and insulin-like growth factor-I, estrogen deficiency in women, diminished testosterone in men, and loss of lean body mass, increased fat, and other changes consistent with hormone deficiencies occur during aging. Treatment of nonelderly GH-deficient adults with recombinant human GH (rhGH) improves body composition, muscle strength, physical function, and bone density, and reduces blood cholesterol and cardiovascular disease risk, but is often accompanied by carpal tunnel syndrome, peripheral edema, joint pain and swelling, gynecomastia, glucose intolerance, and possibly increased cancer risk. Reports that rhGH augments lean body mass and reduces body fat in aged individuals increased use of rhGH to delay aging effects. However, clinically significant functional benefits, prolongation of youth, and life extension have not been demonstrated. Moreover, marketing of rhGH and other hormone supplements largely ignores adverse effects. Until more research has better defined the risk/benefit relationships, treatment of elderly individuals with rhGH should be confined to controlled research studies.
Kronos Longevity Research Institute, 2222 E. Highland, Suite 220, Phoenix, AZ 85016, USA. mitch.harman@kronosinstitute.org
S Mitchell
SM
Harman
Marc R
MR
Blackman
D000367:Age Factors; D000368:Aged; D002986:Clinical Trials as Topic; D005853:Geriatrics; D019382:Human Growth Hormone / Q000172:deficiency* / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors
D019382:Human Growth Hormone